Efficacy and safety of <sup>188</sup>Re-HEDP in lung cancer patients with bone metastases: a randomized, multicenter, multiple-dose phase IIa study.

导出原文传递

翻译打印收藏纠错

第一作者： Ping,Chen

第一单位： Department of Nuclear Medicine, Huashan Hospital, Fudan University, Jing'an District, No.12 Urumchi Middle Road, Shanghai, 200040, China.

作者： Ping,Chen ^[1] ; Jun,Li ^[2] ; Jicong,Gui ^[1] ; Congjin,Liu ^[1] ; Yuankai,Wang ^[1] ; Guangming,Zhang ^[1] ; Dayu,Kuai ^[1] ; Yiwei,Wu ^[1] ; Zengli,Liu ^[3] ; Changjing,Zuo ^[4] ; Zhongwei,Lv ^[5] ; Yingjian Biao,ZhangLi ^[6] ; Xingdang,Liu ^[7]

作者单位： Department of Nuclear Medicine, Huashan Hospital, Fudan University, Jing'an District, No.12 Urumchi Middle Road, Shanghai, 200040, China. ^[1] Department of Nuclear Medicine, Pudong Hospital, Fudan University, Shanghai, China. ^[2] Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China. ^[3] Department of Nuclear Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China. ^[4] Department of Nuclear Medicine, Shanghai Changhai Hospital, Navy Military Medical University, Shanghai, China. ^[5] Department of Nuclear Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China. ^[6] Department of Nuclear Medicine, Shanghai Cancer Center, Fudan University, Shanghai, China. ^[7] Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ^[8] Department of Nuclear Medicine, Huashan Hospital, Fudan University, Jing'an District, No.12 Urumchi Middle Road, Shanghai, 200040, China. xingdliu@fudan.edu.cn. ^[9] Department of Nuclear Medicine, Pudong Hospital, Fudan University, Shanghai, China. xingdliu@fudan.edu.cn. ^[10]

关键词 188Re-HEDP Bone metastases Lung cancer